Monday, March 02, 2015 1:28:21 AM
Published: 26 February 2015
ORLANDO, FL, USA (UroToday.com) - Given the conflicting data on of the effect of prostate cancer screening on the reduction in mortality, along with the known high numbers needed to screen and treat, a number of groups have focused their efforts on biomarkers that can provide improved risk stratification. Harms of prostate biopsy include increasing risk of infection, urinary complications, costs, and emotional stress. Thus, better markers that are focused on identification of aggressive cancers are needed so that biopsy can be foregone in a number of men who are not at risk of death from disease. Dr. Sanoj Punnen from the University of Miami presented his group’s data on a new test, the 4K Score.
The 4K Score is a blood test that combines four kallikrein assays with clinical information in an algorithm that reports the probability of high-grade prostate cancer on biopsy of the prostate. The seven elements of the 4K Score include total PSA, free PSA, intact PSA, and hK2, along with DRE, prior biopsy, and patient age. The test was used prospectively at 26 U.S. centers in 1 000 men scheduled for prostate biopsy regardless of PSA or clinical findings. The primary outcome assessed was finding of Gleason 3+4 (defined as high-risk) prostate cancer on TRUS biopsy.
The group found Gleason 3+4 in 10.7% of patients (23% of cancers), 4+3 in 5.8% of patients (12.6%), Gleason 8 in 3.5% of patients (7.4%), Gleason 9 in 2.6% of patients (5.5%) and Gleason 10 in 0.3% of patients (0.6%). Overall, 22.8% of patients had high-risk disease, while 77.2% had negative biopsies or Gleason 6 cancer. The 4K Score demonstrated near perfect calibration when comparing actual to predicted high risk cancer, and had a greater accuracy when comparing AUC (0.82) vs that of the PCPT 2.0 (0.74, p < 0.0001). If a 9% probability of high-grade cancer was used as a threshold for biopsy of the prostate, 434 (43%) unnecessary biopsies could have been avoided, while delaying diagnosis of only 24 (2.4%) high-grade cancers.
Dr. Punnen concluded that the 4K Score is accurate in the detection of high grade prostate cancer, can provide personalized risk prediction, and can lead to a significant reduction in unnecessary prostate biopsies.
Presented by Sanoj Punnen, MD at the 2015 Genitourinary Cancers Symposium - "Integrating Biology Into Patient-Centric Care" - February 26 - 28, 2015 - Rosen Shingle Creek - Orlando, Florida USA
University of Miami, Coral Gables, FL USA
Reported by Nikhil Waingankar, MD, medical writer for UroToday.com
Recent OPK News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/20/2024 06:56:10 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/18/2024 08:13:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 09:00:42 PM
- Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/30/2024 09:01:33 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/23/2024 09:33:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:23:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:50:25 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/12/2024 10:27:05 PM
- Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/09/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:39:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:12:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:07:42 PM
- OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:06:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:21:51 PM
- OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 09:03:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:49:22 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/26/2024 11:43:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:18:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:11:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:08:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 11:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 09:16:09 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM